These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 27712594)

  • 1. MicroRNA-21 Regulates the Proliferation, Differentiation, and Apoptosis of Human Renal Cell Carcinoma Cells by the mTOR-STAT3 Signaling Pathway.
    Liang T; Hu XY; Li YH; Tian BQ; Li ZW; Fu Q
    Oncol Res; 2016; 24(5):371-380. PubMed ID: 27712594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-182 affects renal cancer cell proliferation, apoptosis, and invasion by regulating PI3K/AKT/mTOR signaling pathway.
    Fu JH; Yang S; Nan CJ; Zhou CC; Lu DQ; Li S; Mu HQ
    Eur Rev Med Pharmacol Sci; 2018 Jan; 22(2):351-357. PubMed ID: 29424922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The IGF-I/JAK2-STAT3/miR-21 signaling pathway may be associated with human renal cell carcinoma cell growth.
    Su Y; Zhao A; Cheng G; Xu J; Ji E; Sun W
    Cancer Biomark; 2017 Jul; 19(3):289-296. PubMed ID: 28453463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR‑539 suppresses proliferation and induces apoptosis in renal cell carcinoma by targeting high mobility group A2.
    Ye ZH; Gui DW
    Mol Med Rep; 2018 Apr; 17(4):5611-5618. PubMed ID: 29436648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-125a suppresses cell migration, invasion, and regulates hyaluronic acid synthase 1 expression by targeting signal transducers and activators of transcription 3 in renal cell carcinoma cells.
    Sun M; Guo S; Yao J; Xiao Y; Sun R; Ma W; Dong Z
    J Cell Biochem; 2019 Feb; 120(2):1894-1902. PubMed ID: 30187954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-coding RNA 886 promotes renal cell carcinoma growth and metastasis through the Janus kinase 2/signal transducer and activator of transcription 3 signaling pathway.
    Lei J; Xiao JH; Zhang SH; Liu ZQ; Huang K; Luo ZP; Xiao XL; Hong ZD
    Mol Med Rep; 2017 Oct; 16(4):4273-4278. PubMed ID: 28765891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miRNA‑205‑5p functions as a tumor suppressor by negatively regulating VEGFA and PI3K/Akt/mTOR signaling in renal carcinoma cells.
    Huang J; Wang X; Wen G; Ren Y
    Oncol Rep; 2019 Nov; 42(5):1677-1688. PubMed ID: 31545453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miRNAs as potential regulators of mTOR pathway in renal cell carcinoma.
    Nogueira I; Dias F; Teixeira AL; Medeiros R
    Pharmacogenomics; 2018 Feb; 19(3):249-261. PubMed ID: 29334302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The preclinical assessment of XL388, a mTOR kinase inhibitor, as a promising anti-renal cell carcinoma agent.
    Xiong Z; Zang Y; Zhong S; Zou L; Wu Y; Liu S; Fang Z; Shen Z; Ding Q; Chen S
    Oncotarget; 2017 May; 8(18):30151-30161. PubMed ID: 28404914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-144 inhibits cell proliferation of renal cell carcinoma by targeting MTOR.
    Xiang C; Cui SP; Ke Y
    J Huazhong Univ Sci Technolog Med Sci; 2016 Apr; 36(2):186-192. PubMed ID: 27072960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miRNA-133b and miRNA-135a induce apoptosis via the JAK2/STAT3 signaling pathway in human renal carcinoma cells.
    Zhou W; Bi X; Gao G; Sun L
    Biomed Pharmacother; 2016 Dec; 84():722-729. PubMed ID: 27710896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-20b-5p functions as a tumor suppressor in renal cell carcinoma by regulating cellular proliferation, migration and apoptosis.
    Li Y; Chen D; Jin L; Liu J; Su Z; Li Y; Gui Y; Lai Y
    Mol Med Rep; 2016 Feb; 13(2):1895-901. PubMed ID: 26708577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. STAT3 regulates miR93-mediated apoptosis through inhibiting DAPK1 in renal cell carcinoma.
    Du Y; Kong C
    Cancer Gene Ther; 2021 May; 28(5):502-513. PubMed ID: 33230258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of c-FLIPL expression by miRNA-708 increases the sensitivity of renal cancer cells to anti-cancer drugs.
    Kim EA; Kim SW; Nam J; Sung EG; Song IH; Kim JY; Kwon TK; Lee TJ
    Oncotarget; 2016 May; 7(22):31832-46. PubMed ID: 27092874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of microRNA-15a suppresses the proliferation and invasion of renal cell carcinoma via direct targeting of eIF4E.
    Li G; Chong T; Xiang X; Yang J; Li H
    Oncol Rep; 2017 Oct; 38(4):1995-2002. PubMed ID: 28849086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SIRT1 downregulated FGB expression to inhibit RCC tumorigenesis by destabilizing STAT3.
    Chen Y; Zhu Y; Sheng Y; Xiao J; Xiao Y; Cheng N; Chai Y; Wu X; Zhang S; Xiang T
    Exp Cell Res; 2019 Sep; 382(2):111466. PubMed ID: 31201813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Over-expression of DNA-PKcs in renal cell carcinoma regulates mTORC2 activation, HIF-2α expression and cell proliferation.
    Zheng B; Mao JH; Li XQ; Qian L; Zhu H; Gu DH; Pan XD
    Sci Rep; 2016 Jul; 6():29415. PubMed ID: 27412013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NKAP promotes renal cell carcinoma growth via AKT/mTOR signalling pathway.
    Ma Q; Hou L; Gao X; Yan K
    Cell Biochem Funct; 2020 Jul; 38(5):574-581. PubMed ID: 32032976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abrogation of STAT3 signaling cascade by zerumbone inhibits proliferation and induces apoptosis in renal cell carcinoma xenograft mouse model.
    Shanmugam MK; Rajendran P; Li F; Kim C; Sikka S; Siveen KS; Kumar AP; Ahn KS; Sethi G
    Mol Carcinog; 2015 Oct; 54(10):971-85. PubMed ID: 24797723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. UBE2T promotes proliferation and regulates PI3K/Akt signaling in renal cell carcinoma.
    Hao P; Kang B; Li Y; Hao W; Ma F
    Mol Med Rep; 2019 Aug; 20(2):1212-1220. PubMed ID: 31173226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.